9 pharma leaders sound ‘alarm bells’ on biotech’s decline in Europe


Frustrated by a slump that’s seen Europe lose ground to the U.S. and China, several top drugmakers are calling for speedier clinical trials, intellectual property protections and “fiscal flexibility.”

एक उत्तर छोड़ें

आपका ईमेल पता प्रकाशित नहीं किया जाएगा। आवश्यक फ़ील्ड को * से चिह्नित किया गया है